FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia - Low, D E; File, T M, Jr; Eckburg, P B; FOCUS 2 investigators (J Antimicrob Chemother, 2011)